VAERS reports by lot

GSK Varicella/Shingles lot XJ57B: VAERS reports

51 VAERS reports list lot XJ57B as a GSK Varicella/Shingles vaccine, received between 2019-07-09 and 2021-11-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
2%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4928%
Injection-site / Local reaction4124%
Musculoskeletal2213%
Neurological1911%
Gastrointestinal137%
Dermatological (non-injection-site)116%
Cardiac / Cardiovascular74%
Respiratory63%
Allergic / Anaphylactic42%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
New Jersey4
Virginia4
Washington4
Arizona3
Michigan3
Indiana3
Florida3
South Carolina2
Oregon2
Illinois2
Ohio2

Reports by month received

2019-0712
2019-0825
2019-094
2019-104
2019-112
2019-122
2020-011
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.